Nanomix is a leader in the development of mobile point-of-care diagnostics, with a hand-held platform and assays that provide rapid, accurate, quantitative information for new use in settings where time is critical to clinical decision making and improved patient care. The company’s products are designed to broadly impact health care delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote, or alternative settings, thus enabling faster clinical decision-making and potentially treatment-in-place.